Navidea Biopharmaceuticals Inc (NAVB):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Navidea Biopharmaceuticals Inc (NAVB) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7224
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Navidea Biopharmaceuticals Inc (Navidea) is a biopharmaceutical company that develops precision immunodiagnostic agents and immunotherapeutics.. The company is focused on developing multiple precision-targeted products based on its Manocept platform to improve patient care. Its pipeline products include MT-1002; MT-2002; Tc99m tilmanocept for Kaposi’s, NAS, Cardiovascular diseases, Sentinal Node Biopsy, and Solid tumors lymphatic mapping and NAV4694 for Alzhemier’s Disease. Navidea by utilizing its Manocept platform develops multiple precision-targeted products to identify pathways of undetected disease and provide better diagnostic accuracy, clinical decision-making and effective treatment. The company has presence in the US, and the UK. Navidea is headquartered in Dublin, Ohio, the US.

Navidea Biopharmaceuticals Inc (NAVB) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Navidea Biopharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Navidea Biopharmaceuticals Inc, Medical Equipment, Deal Details 10
Partnerships 10
Sayre Therapeutics Enters into Licensing Agreement with Navidea Biopharma 10
Cerveau to Enter into Licensing Agreement with Navidea Biopharma 11
Equity Offering 12
Navidea Biopharma Raises USD3 Million in Private Placement of Shares 12
Navidea Biopharma Plans to Raise up to USD100 in Public Offering of Shares 13
Navidea Biopharma Completes Private Placement Of Units For US$30 Million 14
Navidea Biopharma Completes Public Offering Of Common Stock For US$5 Million 16
Navidea Biopharma Completes Private Placement Of Shares For US$5 Million 17
Navidea Biopharma Completes Private Placement Of Shares For US$2 Million Upon Exercise Of Warrants 19
Navidea Biopharmaceuticals Inc – Key Competitors 20
Navidea Biopharmaceuticals Inc – Key Employees 21
Navidea Biopharmaceuticals Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 08, 2018: Navidea Biopharmaceuticals reports second quarter 2018 financial results 23
May 08, 2018: Navidea Biopharmaceuticals Announces First Quarter 2018 Financial Results 24
Mar 08, 2018: Navidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results 25
Nov 08, 2017: Navidea Biopharmaceuticals Reports Third Quarter 2017 Financial Results 27
May 09, 2017: Navidea Biopharmaceuticals Reports First Quarter 2017 Financial Results 29
Mar 29, 2017: Navidea Provides Corporate Update and Reports Full Year 2016 Results 31
Corporate Communications 34
Aug 17, 2018: Navidea Biopharmaceuticals announces results of the Annual Shareholder Meeting 34
Legal and Regulatory 35
Aug 15, 2018: Navidea Biopharmaceuticals receives noncompliance notice from NYSE American 35
Product News 36
Nov 01, 2017: Navidea to Present Late-Breaking Abstract at American College of Rheumatology Annual Meeting 36
Apr 25, 2017: Navidea Biopharmaceuticals Invited to Present Data at Two Major Upcoming Conferences 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Navidea Biopharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Navidea Biopharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Navidea Biopharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sayre Therapeutics Enters into Licensing Agreement with Navidea Biopharma 10
Cerveau to Enter into Licensing Agreement with Navidea Biopharma 11
Navidea Biopharma Raises USD3 Million in Private Placement of Shares 12
Navidea Biopharma Plans to Raise up to USD100 in Public Offering of Shares 13
Navidea Biopharma Completes Private Placement Of Units For US$30 Million 14
Navidea Biopharma Completes Public Offering Of Common Stock For US$5 Million 16
Navidea Biopharma Completes Private Placement Of Shares For US$5 Million 17
Navidea Biopharma Completes Private Placement Of Shares For US$2 Million Upon Exercise Of Warrants 19
Navidea Biopharmaceuticals Inc, Key Competitors 20
Navidea Biopharmaceuticals Inc, Key Employees 21
Navidea Biopharmaceuticals Inc, Subsidiaries 22

List of Figures
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Navidea Biopharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Navidea Biopharmaceuticals Inc (NAVB):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • New Image Group Ltd:企業の戦略的SWOT分析
    New Image Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Eurus Energy Holdings Corp:電力:M&Aディール及び事業提携情報
    Summary Eurus Energy Holdings Corp (Eurus Energy), a subsidiary of Toyota Tsusho Corporation, is a renewable energy company that generates power through various renewable sources such as wind and solar photovoltaic. The company's services include location survey, wind or sunlight study, basic design …
  • Helix BioPharma Corp (HBP):企業の財務・戦略的SWOT分析
    Helix BioPharma Corp (HBP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Ballast Nedam NV:企業の戦略・SWOT・財務情報
    Ballast Nedam NV - Strategy, SWOT and Corporate Finance Report Summary Ballast Nedam NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Neovasc Inc (NVC):企業の財務・戦略的SWOT分析
    Summary Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include Neovasc reducer, Neovasc tiara, and Neovasc tissue products. Its Neovasc tiara is a novel transcatheter device that is design …
  • Telephonics Corporation:企業の戦略的SWOT分析
    Telephonics Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • ADx NeuroSciences NV:企業の製品パイプライン分析2018
    Summary ADx NeuroSciences NV (ADx NeuroSciences) is a medical device company that develops proprietary biomarkers for various neurodegenerative diseases. The company offers biomarkers for Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. It also develops and commercializes analyti …
  • ALK-Abello AS (ALK B):企業の財務・戦略的SWOT分析
    ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • AirAsia Berhad:戦略・SWOT・企業財務分析
    AirAsia Berhad - Strategy, SWOT and Corporate Finance Report Summary AirAsia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Menicon Co Ltd (7780)-医療機器分野:企業M&A・提携分析
    Summary Menicon Co Ltd (Menicon) is a medical device company that manufactures, export, import and markets ophthalmic products. The company’s products include soft contact lens, hard contact lens, astigmatic contact lens and bifocal contact lenses, among others. It offers contact lens care products …
  • Energy Resources of Australia Ltd. (ERA):企業の財務・戦略的SWOT分析
    Energy Resources of Australia Ltd. (ERA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Mindray Medical International Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Mindray Medical International Ltd (Mindray Medical) is a developer, manufacturer and marketer of medical devices and solutions. The company offers products for patient monitoring and life support, in-vitro diagnostics, veterinary, and medical imaging systems. Its major products include patie …
  • La-Z-Boy Incorporated:企業の戦略・SWOT・財務分析
    La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report Summary La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Nippon Express Co Ltd (9062):企業の財務・戦略的SWOT分析
    Nippon Express Co Ltd (9062) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • AMETEK, Inc.:企業の戦略・SWOT・財務情報
    AMETEK, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMETEK, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Urigen Pharmaceuticals Inc:企業の戦略的SWOT分析
    Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Valmet Corp (VALMT):企業の財務・戦略的SWOT分析
    Valmet Corp (VALMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Bonduelle Sca:企業の戦略・SWOT・財務分析
    Bonduelle Sca - Strategy, SWOT and Corporate Finance Report Summary Bonduelle Sca - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Nostrum Oil & Gas PLC (NOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Nostrum Oil & Gas PLC (Nostrum) is an independent oil and gas company. It produces, develops, and explores for oil and gas in the pre-Caspian Basin. The company produces crude oil, stabilized liquid condensate, LPG and dry gas. Nostrum has commercial hydrocarbon reserves in the Ardatovski, L …
  • T-System Inc-医療機器分野:企業M&A・提携分析
    Summary T-System Inc (T-System) is a healthcare service provider that offers clinical, financial, operational, and regulatory solutions. The company offers documentation solutions, which include EV, an emergency department information system; EV for physicians, a solution with ER-specific clinical c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆